£1.6M
The funding round was led by Archangels to support product development and market entry.
B
Biocaptiva
Biocaptiva develops technology designed to improve liquid biopsy testing for cancer management.
Edinburgh, UK—Founded 2018
£4.7MTotal raised
Biocaptiva is a Scottish medical technology company developing the BioCaptis device to capture cell-free DNA for cancer management.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Biocaptiva's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Investors
- £1.6MOld College CapitalFollow-on
Scottish EnterpriseFollow-on
- £2.1M
- £1.0M
Funding history
£2.1M
The funding round was led by Archangels to support human trials of the BioCaptis device.
£1.0M
The University of Edinburgh spin-out has secured backing to fund its first human trials.